Description

Benzeneacetamide, N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-α-hydroxy- is a specialized heterocyclic organic compound featuring a complex molecular architecture that combines a benzeneacetamide moiety with a modified uracil (pyrimidine) ring system. This compound matters as a high-value pharmaceutical intermediate and research chemical, enabling the synthesis of novel active pharmaceutical ingredients (APIs) and facilitating advanced medicinal chemistry research. It is primarily needed by R&D laboratories, pharmaceutical manufacturers, and fine chemical producers focused on developing new therapeutic agents, particularly in areas like oncology and antiviral drug discovery.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel nucleoside analogs and other complex active pharmaceutical ingredients (APIs).
• Medicinal Chemistry Research: Used in drug discovery programs for structure-activity relationship (SAR) studies and lead optimization.
• Biochemical Research: Serves as a precursor or reference standard in enzymatic and receptor-binding studies.
• Fine Chemical Synthesis: Employed in the multi-step synthesis of complex, high-value specialty chemicals for various industrial applications.
• Academic Research: Utilized in universities and research institutes for exploring new synthetic methodologies and heterocyclic chemistry.

Basic Information

Product Name	Benzeneacetamide, N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-α-hydroxy-
CAS No.	314774-00-0
Molecular Formula	C15H18N4O4
Molecular Weight	318.33 g/mol
Synonyms	N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-α-hydroxybenzeneacetamide; 2-[(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)amino]-2-oxo-1-phenylethanol; 5-[(2-Hydroxy-2-phenylacetyl)amino]-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; 5-[(α-Hydroxyphenylacetyl)amino]-1,3-dimethyluracil; 1,3-Dimethyl-5-[(α-hydroxyphenylacetamido)]uracil; Benzeneacetic acid, α-hydroxy-, 2-[(6-amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)amino]-2-oxoethyl ester (tautomeric form).
EINECS	Contact for details

Quality Control

Our Benzeneacetamide, N-(6-Amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)-α-hydroxy- is produced under a strict quality management system. Every batch undergoes rigorous analytical testing to ensure high purity and consistent identity, meeting the stringent requirements for pharmaceutical R&D and fine chemical synthesis. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to guarantee full traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.